HAL (France)
open access
Automated quantification of Epstein-Barr virus in whole blood for post-transplant lymphoproliferative disorders monitoring
Abstract Background Standardized and sensitive assays for Epstein Barr Virus (EBV) are needed to define universal cutoff for treatment initiation in allogeneic hematopoietic stem cells transplant recipients. In a context of accreditation and the availability of EBV international standard, we evaluat
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Role of CK18F in Predicting Graft-Versus-Host Disease (GvHD)#917891
- Impact of COVID-19 Pandemic on Allogeneic Stem Cell Transplantation Organization : a French Experience#1085884
- Response Prediction in EBV-HLH Using Metabonomics Analysis#869860
- Impact Of Blood Transfusion On Clinical Outcome Of Autologous Haematopoietic STEM Cell Transplantation (Hsct) Patients In Hospital Usm#352715
- Epstein-Barr Detection in Oral Cancer#1230568
Record · ID 1235676
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive